Balkrishna Industries has a good export presence as 83% of FY22 volumes for the company came from exports. The company has a strong presence in Europe, contributing to 51.6% of the total revenue. According to the company’s recent earnings call, the global market share of the company was about 5%-6%. In segmental sales, the agriculture segments had the majority share of 65.5% in volumes for FY22.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This